Category Archives: Uncategorized

Optic neuropathy after influenza vaccination

The authors described a case of a 6-year-old girl who developed bilateral optic neuritis following inactivated influenza vaccination. Source: AAO

Posted on: Feb 19 2020
By: Saratoga Opthalmology
Leave a response

Macular OCT measurements holds potential as a biomarker of cognitive function

In a cross-sectional, population-based survey, the authors determined the association between retinal thickness and cognitive function. Source: AAO

Posted on: Feb 18 2020
By: Saratoga Opthalmology
Leave a response

Week in review: ROP detection, AMD therapy, DME drops

This week, an artificial intelligence algorithm for ROP gains breakthrough designation, a gene therapy for wet AMD shows promise and novel dexamethasone eye drops effectively treat DME. Source: AAO

Posted on: Feb 14 2020
By: Saratoga Opthalmology
Leave a response

Teprotumumab shows convincing phase 3 outcomes for thyroid eye disease

This a randomized, double-masked, placebo-controlled, phase 3 multicenter trial evaluating the insulin-like growth factor I receptor (IGF-IR) inhibitor teprotumumab for treating thyroid eye disease. Source: AAO

Posted on: Feb 13 2020
By: Saratoga Opthalmology
Leave a response

OCT useful for managing invisible retinoblastoma tumors

This paper describes OCT-guided localization and photocoagulation of invisible retinoblastoma tumors in pediatric patients. Source: AAO

Posted on: Feb 12 2020
By: Saratoga Opthalmology
Leave a response

Transepithelial and accelerated protocols linked to reduced CXL efficacy

This prospective study investigated 1-year outcomes of various corneal crosslinking (CXL) techniques for treating progressive keratoconus. Source: AAO

Posted on: Feb 11 2020
By: Saratoga Opthalmology
Leave a response

Coronavirus kills Chinese whistleblower ophthalmologist

Li Wenliang, MD, a 34-year-old ophthalmologist working in Wuhan where the coronavirus epidemic originated, has died. Source: AAO

Posted on: Feb 10 2020
By: Saratoga Opthalmology
Leave a response

Bevacizumab leads to low rates of retinal detachment in infants with ROP

This retrospective analysis reviewed the short-term risk of retinal detachment among infants requiring treatment for type 1 ROP. Source: AAO

Posted on: Feb 10 2020
By: Saratoga Opthalmology
Leave a response

Week in review: Whistleblower death, occupational hazard, enhanced streaming

This week, the Chinese ophthalmologist who issued the first warnings about the coronavirus succumbs to the disease, a nightclub technician develops photokeratitis while on the job and Comcast aims to improve streaming experiences for the visually impaired. Source: AAO